EE Impact

Adamed

Poland · Pharma & Healthcare

LeaveRussia detail: Suspension

Operations suspended

Adamed is an international pharmaceutical and biotechnology company.

Status last verified 03/08/2026Source checked 10/06/2025Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 23/02/2023 · Reference ↗

Halt sales and production in Russia. Revenue decreased in 2024 vs 2023 by more than -20%.

Local stats (LeaveRussia)

Assets(RF), mln.USD
0
Revenue(RF), mln.USD
1
Taxes(RF), mln.USD
1
Staff(RF), 2021
19

Status history since 2022

  1. 03/08/2026 suspended · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.